Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoprolol in hypertrophic obstructive cardiomyopathy
2017-004478-32Phase 2Completed
- Sponsor
- Aarhus University Hospital
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of metoprolol in Hypertrophic Obstructive Cardiomyopathy (HOCM), sponsored by Aarhus University Hospital. Primary endpoint: Pulmonary capillary wedge pressure reduction. Started Dec 2017; status: completed.
02
Drugs
metoprolol
03
Conditions
Hypertrophic Obstructive Cardiomyopathy (HOCM)
Beyond the preview
Go deeper on 2017-004478-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004478-32.